Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Biong, Margarethe ^a   Gram, Inger T ^b   Brill, Ilene ^c   Johansen, Fredrik ^a   Solvang, Hiroko K ^a,d   Alnaes, Grethe Ig ^a   Fagerheim, Toril ^e   Bremnes, Yngve ^b   Chanock, Stephen J ^f,g   Burdett, Laurie ^g   Yeager, Meredith ^g   Ursin, Giske ^d,h   Kristensen, Vessela N ^a,i  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN ACID LABILE SUBUNIT; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG; CARRIER PROTEIN; GLYCOPROTEIN; IGFBP3 PROTEIN, HUMAN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BODY MASS; BREAST TUMOR; GENETICS; MIDDLE AGED;

AGED; BODY MASS INDEX; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; GENOTYPE; GLYCOPROTEINS; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MAMMOGRAPHY; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; TUMOR MARKERS, BIOLOGICAL;

EID: 77950868184     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-9     Document Type: Article

References (69)

1. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. JA Harvey VE Bovbjerg, Radiology 2004 230 29 41 10.1148/radiol.2301020870 14617762
2. Mammographic breast density as an intermediate phenotype for breast cancer. NF Boyd JM Rommens K Vogt V Lee JL Hopper MJ Yaffe, et al. Lancet Oncol 2005 6 798 808 10.1016/S1470-2045(05)70390-9 16198986
3. Mammographic features and breast cancer risk: effects with time, age, and menopause status. C Byrne C Schairer J Wolfe N Parekh M Salane LA Brinton, et al. J Natl Cancer Inst 1995 87 1622 1629 10.1093/jnci/87.21.1622 7563205
4. Effects of mammographic density and benign breast disease on breast cancer risk (United States). C Byrne C Schairer LA Brinton J Wolfe N Parekh M Salane, et al. Cancer Causes Control 2001 12 103 110 10.1023/A:1008935821885 11246838
5. Studying mammographic density: implications for understanding breast cancer. C Byrne, J Natl Cancer Inst 1997 89 531 533 10.1093/jnci/89.8.531 9106636
6. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. G Ursin L Hovanessian-Larsen YR Parisky MC Pike AH Wu, Breast Cancer Res 2005 7 605 R608 10.1186/bcr1260 16168104
7. Breast differentiation and its implication in cancer prevention. J Russo D Mailo YF Hu G Balogh F Sheriff IH Russo, Clin Cancer Res 2005 11 931s 936s 15701889
8. Mammographic breast density and family history of breast cancer. E Ziv J Shepherd R Smith-Bindman K Kerlikowske, J Natl Cancer Inst 2003 95 556 558 12671024
9. Postmenopausal hormone therapy and change in mammographic density. GA Greendale BA Reboussin S Slone C Wasilauskas MC Pike G Ursin, J Natl Cancer Inst 2003 95 30 37 12509398 (Pubitemid 36124293)
10. Polymorphisms in steroid hormone pathway genes and mammographic density. CA Haiman SE Hankinson VI De C Guillemette N Ishibe DJ Hunter, et al. Breast Cancer Res Treat 2003 77 27 36 10.1023/A:1021112121782 12602902 (Pubitemid 36182914)
11. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. RM Tamimi DG Cox P Kraft MN Pollak CA Haiman I Cheng, et al. Breast Cancer Res 2007 9 18 10.1186/bcr1655 17300730
12. Heritability of mammographic density, a risk factor for breast cancer. NF Boyd GS Dite J Stone A Gunasekara DR English MR McCredie, et al. N Engl J Med 2002 19;347 886 894 10.1056/NEJMoa013390
13. The heritability of mammographically dense and nondense breast tissue. J Stone GS Dite A Gunasekara DR English MR McCredie GG Giles, et al. Cancer Epidemiol Biomarkers Prev 2006 15 612 617 10.1158/1055-9965.EPI-05-0127 16614099
14. Can genes for mammographic density inform cancer aetiology? LE Kelemen TA Sellers CM Vachon, Nat Rev Cancer 2008 8 812 823 10.1038/nrc2466 18772892
15. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. LJ Martin NF Boyd, Breast Cancer Res 2008 10 201 10.1186/bcr1831 18226174
16. Insulin-like growth factor physiology and cancer risk. M Pollak, Eur J Cancer 2000 36 1224 1228 10.1016/S0959-8049(00)00102-7 10882860 (Pubitemid 30407009)
17. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. M Verheus JD McKay R Kaaks F Canzian C Biessy M Johansson, et al. Breast Cancer Res Treat 2007 112 109 122 10.1007/s10549-007-9827-x 18064566
18. The association of breast mitogens with mammographic densities. NF Boyd J Stone LJ Martin R Jong E Fishell M Yaffe, et al. Br J Cancer 2002 87 876 882 10.1038/sj.bjc.6600537 12373602 (Pubitemid 35252963)
19. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. C Diorio M Pollak C Byrne B Masse N Hebert-Croteau M Yaffe, et al. Cancer Epidemiol Biomarkers Prev 2005 14 1065 1073 10.1158/1055-9965.EPI-04- 0706 15894654
20. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. C Byrne GA Colditz WC Willett FE Speizer M Pollak SE Hankinson, Cancer Res 2000 60 3744 3748 10919644 (Pubitemid 32204562)
21. Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women. Y Bremnes G Ursin N Bjurstam S Rinaldi R Kaaks IT Gram, Cancer Epidemiol Biomarkers Prev 2007 16 57 62 10.1158/1055-9965.EPI-06-0788 17220332 (Pubitemid 46174264)
22. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. SE Hankinson WC Willett GA Colditz DJ Hunter DS Michaud B Deroo, et al. Lancet 1998 351 1393 1396 10.1016/S0140-6736(97)10384-1 9593409
23. NCBI. OMIM, 2008 Ref Type: Electronic Citation
24. Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. C Diorio S Berube C Byrne B Masse N Hebert-Croteau M Yaffe, et al. Cancer Res 2006 66 588 597 10.1158/0008-5472.CAN-05-1959 16397276 (Pubitemid 43166068)
25. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. F Canzian JD McKay RJ Cleveland L Dossus C Biessy S Rinaldi, et al. Br J Cancer 2006 94 299 307 10.1038/sj.bjc.6602936 16404426
26. The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. YR Boisclair RP Rhoads I Ueki J Wang GT Ooi, J Endocrinol 2001 170 63 70 10.1677/joe.0.1700063 11431138
27. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells. Z Chen Y Ge N Landman JX Kang, BMC Cancer 2002 2:18 18 10.1186/1471-2407-2-18 (Pubitemid 38851303)
28. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. M Harrela H Koistinen J Kaprio M Lehtovirta J Tuomilehto J Eriksson, et al. J Clin Invest 1996 98 2612 2615 10.1172/JCI119081 8958225
29. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort 60. I Cheng KL Penney DO Stram ML Le E Giorgi CA Haiman, et al. Cancer Epidemiol Biomarkers Prev 2006 15 1993 1997 10.1158/1055-9965.EPI-06-0361 17035411
30. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women 61. Z Ren Q Cai XO Shu H Cai C Li H Yu, et al. Cancer Epidemiol Biomarkers Prev 2004 13 1290 1295 15298948 (Pubitemid 39071551)
31. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer 62. A Al-Zahrani MS Sandhu RN Luben D Thompson C Baynes KA Pooley, et al. Hum Mol Genet 2006 15 1 10 10.1093/hmg/ddi398 16306136 (Pubitemid 43020099)
32. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. H Johansson S Gandini B Bonanni F Mariette A Guerrieri-Gonzaga D Serrano, et al. Breast Cancer Res Treat 2007 108 57 67 10.1007/s10549-007-9577-9 17468953
33. Percentage density, Wolfe's and Tabar's mammographic patterns: agreement and association with risk factors for breast cancer. IT Gram Y Bremnes G Ursin G Maskarinec N Bjurstam E Lund, Breast Cancer Res 2005 7 854 R861 10.1186/bcr1308 16168132
34. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Y Bremnes G Ursin N Bjurstam S Rinaldi R Kaaks IT Gram, Int J Cancer 2007 121 2506 2511 10.1002/ijc.22971 17657735 (Pubitemid 350022421)
35. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Y Bremnes G Ursin N Bjurstam E Lund IT Gram, Int J Cancer 2007 120 880 884 10.1002/ijc.22437 17131324 (Pubitemid 46175410)
36. Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study. Y Bremnes G Ursin N Bjurstam IT Gram, Breast Cancer Res 2007 9 73 10.1186/bcr1782 17963507
37. Breast cancer screening programme as setting for an adjunct research project: effect on programme attendance. IT Gram E Lund, J Med Screen 2008 15 44 45 10.1258/jms.2008.007014 18416955
38. The detection of changes in mammographic densities. G Ursin MA Astrahan M Salane YR Parisky JG Pearce JR Daniels, et al. Cancer Epidemiol Biomarkers Prev 1998 7 43 47 9456242
39. W Czika X Yu, SAS/Genetics PROC HAPLOTYPE SAS Help Documentation 2003 Ref Type: Computer Program
40. Gene Frequencies and Linkage Disequilibrium. Genetic Analysis of Complex Traits Using SAS. W Czika X Yu, NC: SAS Publishing, Arnold Myron Saxton, 2004
41. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. DV Zaykin PH Westfall SS Young MA Karnoub MJ Wagner MG Ehm, Hum Hered 2002 53 79 91 10.1159/000057986 12037407
42. An analysis of transformations. GEP Box DR Cox, Journal of the Royal Statistical Society 1964 26 211 522
43. GB Dantzig MN Thapa, Linear Programming:Theory and Extensions Princeton, Princeton University Press 1963
44. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. MC Pike MD Krailo BE Henderson JT Casagrande DG Hoel, Nature 1983 303 767 770 10.1038/303767a0 6866078
45. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. IT Gram T Norat S Rinaldi L Dossus A Lukanova B Tehard, et al. Int J Obes (Lond) 2006 30 1623 1631 10.1038/sj.ijo.0803324 16552400
46. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. JH Lai D Vesprini W Zhang MJ Yaffe M Pollak SA Narod, Cancer Epidemiol Biomarkers Prev 2004 13 573 582 15066922 (Pubitemid 38737893)
47. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. SSI dos N Johnson SB De G Torres-Mejia O Fletcher DS Allen, et al. Cancer Epidemiol Biomarkers Prev 2006 15 449 455 10.1158/1055-9965.EPI-05-0555 16537700
48. IGF-I and mammographic density in four geographic locations: a pooled analysis. G Maskarinec Y Takata Z Chen IT Gram C Nagata I Pagano, et al. Int J Cancer 2007 121 1786 1792 10.1002/ijc.22834 17520679
49. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. NE Allen AW Roddam DS Allen IS Fentiman SSI dos J Peto, et al. Br J Cancer 2005 92 1283 1287 10.1038/sj.bjc.6602471 15756268
50. Serum insulin-like growth factor-I and breast cancer. P Toniolo PF Bruning A Akhmedkhanov JM Bonfrer KL Koenig A Lukanova, et al. Int J Cancer 2000 88 828 832 10.1002/1097-0215(20001201)88:5<828::AID-IJC223.0.CO;2-8 11072255
51. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. RA Krajcik ND Borofsky S Massardo N Orentreich, Cancer Epidemiol Biomarkers Prev 2002 11 1566 1573 12496045
52. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. H Yu XO Shu BD Li Q Dai YT Gao F Jin, et al. Cancer Epidemiol Biomarkers Prev 2003 12 1067 1073 14578144
53. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. AG Renehan M Zwahlen C Minder ST O'Dwyer SM Shalet M Egger, Lancet 2004 363 1346 1353 10.1016/S0140-6736(04)16044-3 15110491
54. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. R Kaaks E Lundin S Rinaldi J Manjer C Biessy S Soderberg, et al. Cancer Causes Control 2002 13 307 316 10.1023/A:1015270324325 12074500
55. Leptin and insulin growth factor I in relation to breast cancer (Greece). E Petridou Y Papadiamantis C Markopoulos E Spanos N Dessypris D Trichopoulos, Cancer Causes Control 2000 11 383 388 10.1023/A:1008903727238 10877331
56. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. H Gronbaek A Flyvbjerg L Mellemkjaer A Tjonneland J Christensen HT Sorensen, et al. Cancer Epidemiol Biomarkers Prev 2004 13 1759 1764 15533904
57. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study 7. Z Kahan J Gardi T Nyari I Foldesi R Hajnal-Papp K Ormandi, et al. Int J Oncol 2006 29 193 200 16773200
58. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? EE Sterns B Zee, Breast Cancer Res Treat 2000 59 125 132 10.1023/A:1006326432340 10817347
59. Insulin-like growth factor-I and estrogen interactions in breast cancer. MB Martin A Stoica, J Nutr 2002 132 3799S 3801S 12468626
60. Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels. C Diorio J Brisson S Berube M Pollak, Cancer Epidemiol Biomarkers Prev 2008 17 880 888 10.1158/1055-9965.EPI-07-2500 18398029
61. Fasting glucose is a risk factor for breast cancer: a prospective study. P Muti T Quattrin BJ Grant V Krogh A Micheli HJ Schunemann, et al. Cancer Epidemiol Biomarkers Prev 2002 11 1361 1368 12433712
62. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. C Deal J Ma F Wilkin J Paquette F Rozen B Ge, et al. J Clin Endocrinol Metab 2001 86 1274 1280 10.1210/jc.86.3.1274 11238520
63. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). AV Patel I Cheng F Canzian ML Le MJ Thun CD Berg, et al. PLoS ONE 2008 3 2578 10.1371/journal.pone.0002578 18596909
64. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. SL Deming Z Ren W Wen XO Shu Q Cai YT Gao, et al. Breast Cancer Res Treat 2007 104 309 319 10.1007/s10549-006-9420-8 17063263
65. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. O Fletcher L Gibson N Johnson DR Altmann JM Holly A Ashworth, et al. Cancer Epidemiol Biomarkers Prev 2005 14 2 19 15668470
66. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. K Bohlke DW Cramer D Trichopoulos CS Mantzoros, Epidemiology 1998 9 570 573 10.1097/00001648-199809000-00018 9730040
67. Insulin-like growth factors in human breast cancer. MJ Ellis S Jenkins J Hanfelt ME Redington M Taylor R Leek, et al. Breast Cancer Res Treat 1998 52 175 184 10.1023/A:1006127621512 10066081
68. Type 1 IGF receptor in human breast diseases. JP Peyrat J Bonneterre, Breast Cancer Res Treat 1992 22 59 67 10.1007/BF01833334 1421425
69. NCBI. Entrez Gene, 2008 Ref Type: Electronic Citation